Safety, Acceptance, and Hesitancy of COVID-19 Vaccines Among High-risk Sub-populations: A Narrative Review

IF 0.3 Q4 PEDIATRICS
T. Alinia, S. Shojaei, Sajjad Rahimi Pordanjani, H. Barati, S. Hovsepian, S. H. Hashemi Nazari, M. Panahi
{"title":"Safety, Acceptance, and Hesitancy of COVID-19 Vaccines Among High-risk Sub-populations: A Narrative Review","authors":"T. Alinia, S. Shojaei, Sajjad Rahimi Pordanjani, H. Barati, S. Hovsepian, S. H. Hashemi Nazari, M. Panahi","doi":"10.32598/jpr.11.1.512.3","DOIUrl":null,"url":null,"abstract":"To end the new COVID-19 pandemic, most of the world’s population needs to be immune to the virus, protecting individuals from infection, and ultimately ensuring herd immunity at the population level. A variety of COVID-19 vaccines have been developed worldwide for adults and children over the age of 12 years, and the effectiveness of the vaccine in preventing symptomatic diseases and hospitalization is being studied. One of the major obstacles to COVID-19 vaccination that has emerged along with the global immunization program is vaccine hesitation or disapproval. The world health organization (WHO) has reported vaccine hesitation as one of the 10 global health threats of 2019. This is also related to COVID-19. The present review, explore the current evidence on COVID-19 vaccination platforms and vaccination efficacy, safety, and adverse effects among strategic sub-populations, including elderly people, people with chronic disease (diabetes, cancer), pregnant and lactating women, children, youth, and vaccination willingness or hesitancy among the target population.","PeriodicalId":43059,"journal":{"name":"Journal of Pediatrics Review","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatrics Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32598/jpr.11.1.512.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

To end the new COVID-19 pandemic, most of the world’s population needs to be immune to the virus, protecting individuals from infection, and ultimately ensuring herd immunity at the population level. A variety of COVID-19 vaccines have been developed worldwide for adults and children over the age of 12 years, and the effectiveness of the vaccine in preventing symptomatic diseases and hospitalization is being studied. One of the major obstacles to COVID-19 vaccination that has emerged along with the global immunization program is vaccine hesitation or disapproval. The world health organization (WHO) has reported vaccine hesitation as one of the 10 global health threats of 2019. This is also related to COVID-19. The present review, explore the current evidence on COVID-19 vaccination platforms and vaccination efficacy, safety, and adverse effects among strategic sub-populations, including elderly people, people with chronic disease (diabetes, cancer), pregnant and lactating women, children, youth, and vaccination willingness or hesitancy among the target population.
高风险亚群中新冠肺炎疫苗的安全性、接受性和犹豫:叙述性综述
为了结束新的新冠肺炎大流行,世界上大多数人口需要对病毒免疫,保护个人免受感染,并最终确保人口层面的群体免疫。世界各地已经为12岁以上的成人和儿童开发了多种新冠肺炎疫苗,目前正在研究该疫苗在预防症状性疾病和住院方面的有效性。与全球免疫计划一起出现的新冠肺炎疫苗接种的主要障碍之一是疫苗犹豫或反对。世界卫生组织(世界卫生组织)报告称,疫苗犹豫是2019年全球十大健康威胁之一。这也与新冠肺炎有关。本综述探讨了新冠肺炎疫苗接种平台和战略亚人群(包括老年人、慢性病(糖尿病、癌症)患者、孕妇和哺乳期妇女、儿童、青年)疫苗接种效果、安全性和不良影响的最新证据,以及目标人群的疫苗接种意愿或犹豫。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
20
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信